| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,452 |
13,500 |
$501K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,483 |
1,177 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,887 |
1,966 |
$27K |
| 80305 |
|
3,350 |
2,700 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
2,587 |
2,075 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
44 |
39 |
$3K |
| 90674 |
|
165 |
122 |
$3K |
| 3008F |
|
3,144 |
2,583 |
$1K |
| 3074F |
|
2,200 |
1,864 |
$930.02 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
136 |
105 |
$920.72 |
| 3078F |
|
1,452 |
1,287 |
$820.02 |
| 3079F |
|
1,468 |
1,258 |
$812.27 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
48 |
41 |
$736.33 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
625 |
418 |
$599.34 |
| 90656 |
|
32 |
32 |
$435.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
17 |
13 |
$299.51 |
| 3075F |
|
529 |
464 |
$283.99 |
| 81003 |
|
224 |
179 |
$236.27 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
16 |
12 |
$129.79 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
19 |
13 |
$126.89 |
| 3077F |
|
84 |
69 |
$82.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
12 |
$26.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
35 |
24 |
$11.76 |
| 99000 |
|
155 |
122 |
$0.00 |